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Executive Summary
The rising burden of chronic disease, and the number of people with complex 
care needs in particular, require the development of delivery systems that bring 
together a range of professionals and skills from both the cure (health-care) and 
care (long-term and social-care) sectors. Failure to better integrate or coordinate 
services along the care continuum may result in suboptimal outcomes and 
available evidence of integrated care programmes points to a positive impact 
on the quality of patient care and improved health or patient satisfaction 
outcomes. However, uncertainty remains about the relative effectiveness of 
different system-level approaches on care coordination and outcomes, with 
particular scarcity of robust evidence on the economic impacts of integrated 
care approaches.
This report provides a summary of published reviews on the economic 
impacts of integrated care approaches. Given the wide range of defi nitions 
and interpretations of the concept, we propose a working defi nition that 
builds on the goal of integrated care and which considers initiatives seeking to 
improve outcomes for those with (complex) chronic health problems and needs 
by overcoming issues of fragmentation through linkage or coordination of 
services of different providers along the continuum of care.
Based on a systematic search of Pubmed, Embase and the Cochrane Library, 
we identifi ed a total of 963 references, of which 19 reviews were identifi ed 
as eligible for inclusion. We analysed reviews for three economic outcomes: 
utilization, cost–effectiveness and cost or expenditure. The latter were 
combined because most studies used these interchangeably. For completeness, 
we also extracted data on core health outcomes such as health status, quality 
of life or mortality, as well as process measures.
None of the reviews identifi ed by our searches explicitly defi ned 
‘integrated care’ as the topic of review. 
The most common concepts or terms were case management, care 
coordination, collaborative care or a combination of these; four reviews focused 
on disease management interventions. The majority of reviews iconsidered 
a wide range of approaches and typically only about half of primary studies 
included in individual reviews could be considered as integrated care under 
our defi nition. Care initiatives frequently targeted the hospital-primary care or 
community services interface, while several reviews examined the coordination 
of primary care and community services, often, although not always, involving 
medical specialists, or extending further into social care services. 
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Utilization and cost were the most common economic outcomes 
assessed by reviews but reporting of measures was inconsistent 
and the quality of the evidence was often low. 
The majority of economic outcomes focused on hospital utilization through 
(re)admission rates, length of stay or admission days and emergency department 
visits. Findings tended to be mixed within each review, which makes it diffi cult 
to draw fi rm conclusions. Also, results were commonly not quantifi ed, making 
an overall assessment of the size of possible effects problematic. Seventeen 
reviews reported cost and/or expenditure data in some form, typically reporting 
cost in terms of health-care cost savings resulting from the intervention, most 
frequently in relation to hospital costs. There was some evidence of cost 
reduction in a number of reviews; however, fi ndings were frequently based on 
a small number of original studies only, or studies that only used a before–after 
design without control, or both. 
There is evidence of cost–effectiveness of selected integrated care 
approaches but the evidence base remains weak. Eight of the nineteen 
studies reported on cost–effectiveness. 
There was some evidence from one review of approaches targeting frequent 
hospital emergency department users that found one trial to report the 
intervention to be cost-effective. Based on one economic evaluation, one other 
review concluded that there was little or no evidence of incremental QALY gain 
over usual care of structured home-based, nurse-led health promotion for older 
people at risk of hospital or care home admission. Six reviews reported on cost 
per QALY as a measure of cost–utility, suggesting increased cost associated 
with the integrated care approach in question in some studies but not others. 
Overall the evidence was diffi cult to interpret.
The majority of studies reviewed echo the concerns reported in earlier 
assessments of the evidence of integrated care interventions. Thus, it remains 
challenging to interpret the evidence from existing primary studies, which tend 
to be characterized by heterogeneity in the defi nition and description of the 
intervention and components of care under study. Variation in defi nitions and 
components of care, and failure to recognize these variations, might lead to 
inappropriate conclusions about programme effectiveness and the application 
of fi ndings.
Based on the evidence presented here, there may be a need to revisit our 
understanding of what integrated care is and what it seeks to achieve, and 
the extent to which the strategy lends itself to evaluation in a way that would 
allow for the generation of clear-cut evidence, given its polymorphous nature. 
Fundamentally, it is important to understand whether integrated care is to be 
considered an intervention that, by implication, ought to be cost-effective and 
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support fi nancial sustainability, or whether it is to be interpreted and evaluated 
as a complex strategy to innovate and implement long-lasting change in the 
way services in the health and social-care sectors are being delivered and 
that involve multiple changes at multiple levels. Evidence presented here and 
elsewhere strongly points to the latter, and initiatives and strategies underway 
will require continuous evaluation over extended periods of time enabling 
assessment of their impacts both economic and on health outcomes if we are 
to generate appropriate conclusions about programme effectiveness and the 
application of fi ndings to inform decision making.
Key messages
• The rising burden of chronic disease and of the number of people with 
complex care needs require the development of delivery systems that bring 
together a range of professionals and skills from both the cure (health-
care) and care (long-term and social-care) sectors. 
• Evidence that is available points to a positive impact of integrated care 
programmes on the quality of patient care and improved health or 
patient satisfaction outcomes but uncertainty remains about the relative 
effectiveness of different approaches and their impacts on costs. 
• This review of published reviews confi rms earlier reports of shortage of 
robust evidence on economic impacts of integrated care.
• The term ‘integrated care’ is often not specifi cally examined; the most 
common concepts or terms were case management, care coordination, 
collaborative care or a combination of these.
• Utilization and cost were the most common economic outcomes assessed 
by reviews but reporting of measures was inconsistent and the quality of 
the evidence was often low.
• There is evidence of cost–effectiveness of selected integrated care 
approaches but the evidence base remains weak.
• There may be a need to revisit our understanding of what integrated care 
is and what it seeks to achieve, and the extent to which the strategy lends 
itself to evaluation in a way that would allow for the generation of clear-
cut evidence.
• It is important to come to an understanding as to whether integrated care 
is to be considered an intervention or whether it is to be interpreted, and 
evaluated, as a complex strategy to innovate and implement long-lasting 
change in the way services in the health and social-care sectors are being 
delivered and that involve multiple changes at multiple levels.
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 1 Background
The rising burden of chronic disease in Europe has been considered the greatest 
challenge to the goal that the European Union has set itself of contributing 
to the achievement of an increase of 2 years in the number of years spent in 
good health by the population in the EU, by 2020 (Council of the European 
Union 2011). Achieving this ambition will require effective measures of disease 
prevention (Novotny, 2008), while also ensuring that those with established 
illness will be able to participate in society. 
Of particular concern is the rapid rise of those with multiple health and care 
needs, which tend to be more common among older people, the proportion 
of whom is also increasing rapidly in the population (European Commission, 
2012). An estimated two-thirds of those who have reached pensionable age 
have at least two chronic conditions (van den Akker et al., 1998; Barnett et al., 
2012). The complexity of needs arising from the nature of multiple chronic 
conditions, in combination with increasing frailty at old age, involving physical, 
developmental or cognitive disabilities, with or without related chronic illnesses 
or conditions, requires the development of delivery systems that bring together 
a range of professionals and skills from both the cure (health-care) and care 
(long-term and social-care) sectors to meet those needs (Nolte & McKee, 2008a).
Yet, service delivery has developed in ways that have tended to fragment 
care, both within and between sectors, through for example structural and 
fi nancial barriers dividing providers at the interfaces of primary/secondary care 
and health/social care; distinct organizational and professional cultures and 
differences in terms of governance and accountability (Glasby, Dickinson & 
Peck, 2006). Failure to better integrate or coordinate services along the care 
continuum may result in suboptimal outcomes, such as potentially preventable 
hospitalization, medication errors or adverse drug events (Vogeli et al., 2007).
Depending on the context, interventions to integrate care are sometimes 
driven by a need to contain cost, sometimes by the need to improve care, 
and often by both. Central to the further development of integrated care is 
an expectation that it might support achievement of the so-called ‘Triple Aim’ 
approach – a simultaneous focus on improving health outcomes, enhancing 
patient care experience and cost reduction (Berwick, Nolan & Whittington, 2008). 
Available evidence points to a positive impact of integrated care programmes 
on the quality of patient care (Ouwens et al., 2005; Mattke, Seid & Ma, 2007), 
and Powell Davies et al. (2006, 2008), in a review of strategies seeking to 
enhance care coordination in selected high-income countries, demonstrated 
that more than half of the 80 studies assessed provided evidence of improved 
health or patient satisfaction outcomes. However, there is still uncertainty 
about the relative effectiveness of different system-level approaches in relation 
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to care coordination, outcomes and economic impact (Ouwens et al., 2005; 
Coleman et al., 2009; de Bruin et al., 2011). This is in part because of the lack 
of a common understanding of what is being referred to as care integration or 
coordination, alongside inconsistencies in describing component interventions 
(Ouwens et al., 2005; Coleman et al., 2009). Importantly, there remains a 
relative lack of scientifi cally rigorous evaluations that would allow for sound 
conclusions of effect given the frequently complex and multicomponent nature 
of related interventions (Suhrcke, Fahey & McKee, 2008).
There is a particular scarcity of robust evidence on the economic impacts of 
integrated care approaches. For example, in a review of systematic reviews 
of the effectiveness of integrated care programmes, Ouwens et al. (2005) 
reported that of the seven (out of 13) systematic reviews that had performed 
economic analyses, four pointed to fi nancial benefi ts but the related evidence 
was based on only a small number of studies. Similarly, the review by Powell 
Davies et al. (2006) identifi ed evidence of positive economic impacts of 
integrated care strategies in fewer than 20 per cent of studies reviewed. More 
recently, De Bruin et al. (2011) reviewed the evidence of the impact of disease 
management programmes on health-care expenditures for patients with 
diabetes, depression, heart failure or chronic obstructive pulmonary disease 
(COPD). Of 21 studies that had examined cost, 13 showed evidence of cost 
savings but these were typically not statistically signifi cant or not tested for 
statistical signifi cance. The authors highlighted that studies varied substantially 
with regard to the interventions, the economic evaluative approach adopted, 
the type of direct health-care costs and cost categories considered, alongside 
a lack of reporting on reliability of estimates, highlighting the need for higher 
quality studies. The work by De Bruin et al. (2011) used a broad defi nition 
of disease management, which built on the chronic care model (Wagner, 
1998) and focused on programmes that contained two or more chronic care 
interventions such as care or case management, self-management support 
or reminder systems and which could be considered as approximating what 
others might refer to as ‘integrated care’ as we shall see below. However, as 
the work focused on interventions for a selected set of health conditions, it 
did not consider studies that examined the economic impact of integrated care 
approaches that target a broader spectrum of service user needs.
This report provides a rapid review of the published evidence on the 
economic impacts of integrated care approaches. We begin by providing 
a conceptualization and working defi nition of ‘integrated care’ that will serve 
as a guide to delineate interventions considered as integrated care approaches 
in the evidence review; this will be followed by a brief discussion of key 
considerations of economic evaluation in the context of integrated care. We 
then describe the methodological approach we used to undertake the review, 
followed by an overview of our fi ndings. We close with a set of observations 
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and discuss the extent to which the available evidence permits derivation of 
robust conclusions on the economic impacts of integrated care approaches.
2 Conceptualizing ‘integrated care’ 
As we have shown previously (Nolte & McKee, 2008b; Nolte, Knai & McKee, 
2008), integrated care is a concept that has been widely but variously used 
in many ways in different health systems. Here we focus our discussion of 
integrated care in relation to chronic illness and multiple care needs although 
it is important to recognize that it is a much broader concept that applies to 
many other areas such as urgent care, maternity and child health care and 
public health, among others.
A key challenge remains the lack of common defi nitions of underlying 
concepts; as a consequence there is a plethora of terminologies that have 
variously been described as ‘integrated care’, ‘coordinated care’, ‘collaborative 
care’, ‘managed care’, ‘disease management’, ‘case management’, ‘health/
social care service user-centred care’, ‘chronic care’, ‘continuity of care’, 
‘seamless care’ and others. While these may differ conceptually, the boundaries 
between them often remain unclear (Kodner & Spreeuwenberg, 2002), and 
there is a general absence of a sound analytical framework through which 
to examine processes of integration (Goodwin et al., 2004; Godwin, 2010). 
This very much refl ects the polymorphous nature of a concept that is applied 
from several disciplinary and professional perspectives and is associated with 
diverse objectives (Nolte & McKee, 2008b). Similarly, given the nature of the 
health-care ‘production’ process with its imprecise boundaries between stages, 
the way service users progress through the system, and the often probabilistic 
nature of the treatment process, providers need to be able to address uncertain 
demand at each stage (Simoens & Scott, 1999). Thus, integration in health care 
is not likely to follow a single path and variations will be inevitable.
In an attempt to develop a typology of integration in health care that 
enables systematic assessment of the structures and processes involved, 
their prerequisites and their effects on health-care organization, delivery and 
outcomes, analysts have identifi ed different dimensions of integration, most 
commonly differentiating the type, breadth, degree and process of integration 
(Nolte & McKee, 2008b).
Examining fi rst the types of integration, we can identify four main forms 
(Shortell, Gillies & Anderson, 1994; Simoens & Scott, 1999; Delnoij, Klazinga 
& Glasgow, 2002):
• Functional: integration of key support functions and activities, such 
as fi nancial management, strategic planning and human resource 
management; 
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• Organizational: for example, creation of networks, mergers, contracting; 
• Professional: for example, joint working, group practices, contracting 
or strategic alliances of health-care professionals within and between 
institutions and organizations; 
• Clinical: integration of the different components of clinical processes, such 
as coordination of care services for individual health-care service users or 
care pathways.
These types can occur in ways that have been described as horizontal 
integration or vertical integration (also referred to as breadth of integration) 
(Shortell, Gillies & Anderson, 1994; Simoens & Scott, 1999). Horizontal 
integration links services that are on the same level in the process of health 
care, for example general practice and community care, that facilitates 
organizational collaboration and communication between providers. Vertical 
integration brings together organizations at different levels of a hierarchical 
structure under one management umbrella, for example primary and secondary 
or specialist care.
Furthermore, integrated care can be realized on a continuum of integration, 
referred to as the degree of integration (Leutz, 1999; Goodwin et al., 2004; 
Ahgren & Axelsson, 2005). The degree can range from full integration in 
which the integrated organization is responsible for the full continuum of care, 
including funding, to collaboration, which describes separate structures in 
which organizations retain their own service responsibility and funding criteria. 
Leutz (1999), drawing on an analysis of initiatives to integrate health and social 
services in the United States and the United Kingdom in the 1990s, proposed 
an ‘integration framework’ that described three levels of integration that he set 
against dimensions of service users’ need to enable a comprehensive approach 
that responds to the varied needs of all persons with chronic or disabling 
conditions. The three levels were identifi ed as:
• Linkage: operates through the separate structures of existing health and 
social services systems, with organizations retaining their own service 
responsibilities, funding and eligibility criteria, and operational rules.
• Coordination: as linkage but involves additional explicit structures and 
processes, such as routinely shared information, discharge planning and 
case managers, to coordinate care across the various sectors.
• Full integration: the integrated organization/system assumes responsibility 
for all services, resources and funding, which may be subsumed in one 
managed structure or through contractual agreements between different 
organizations.
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Leutz (1999) placed service user need at the core of the integrated care 
initiative, arguing that people with low levels of need as defi ned, for example, 
by the stability and severity of the condition, duration of illness, scope of 
services required and the user’s capacity for self-direction, might not require a 
fully integrated system, while more integrated approaches should be targeted 
at those with highest need (Fig. 1).
Fig. 1 Levels of integration and user need as described by Leutz (1999).
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Source: Nolte & McKee (2008b).
An alternative approach to classifying integrated care builds on the actual 
processes of integration. Thus, Fulop, Mowlem & Edwards (2005) distinguished 
normative integration, in which shared values play a core part in coordinating 
and securing collaboration in the delivery of care, from systemic integration, 
where rules and policies are coherently implemented at the various levels of 
the organization. A similar notion was proposed by Fabbricotti (2007). At the 
same time it is important to highlight that the process of integration typically 
requires simultaneous action at different levels, involving different functions 
and, importantly, develops in distinct phases (Minkman, 2011).
Meanwhile, in an attempt to further structure the fi eld of research on integrated 
care, the International Journal of Integrated Care has described four broad 
categories of research activity (Schrijvers & Goodwin, 2010):
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• Integration of health and social services;
• Integration between primary health care and hospital care;
• Integrated care within one sector (for example, mental health services); 
• Integration between preventive and curative services.
These attempts towards developing a typology provide important tools for the 
systematic assessment of integrated care. However, as noted earlier, the way 
in which the integration terminology is currently being employed in practice 
varies considerably. Therefore, in order to undertake a review of the available 
evidence of impact it will be crucial to adopt a more pragmatic working 
defi nition of integrated care. 
We propose a working defi nition that builds on the goal of integrated care and 
which can be described as:
 Initiatives seeking to improve outcomes for those with (complex) chronic 
health problems and needs by overcoming issues of fragmentation 
through linkage or coordination of services of different providers along 
the continuum of care. 
We use the terms ‘initiative’ or ‘approach’ to highlight the fact that efforts to 
integrate care typically involve a complex set of multiple interventions acting at 
different levels and, as noted earlier, evolving and adapting over time. Where 
we use the term ‘intervention’, we take this to mean ‘complex intervention’ to 
emphasize the complexity of the integrated care efforts. We recognize that the 
working defi nition neglects integration efforts within provider organizations 
such as the implementation of clinical pathways or the use of specialist nurses 
within organizations. 
3 Conceptualizing economic impact in integrated care
Initiatives to integrate care are frequently driven by a need to contain cost; 
yet, investing in integrated care does not necessarily imply an economic gain 
(Vondeling, 2004). This will depend on the part of the cost associated with 
the disease burden or level of need that can be averted or reduced through 
the intervention set against the cost of carrying out the initiative in question 
(Suhrcke, Fahey & McKee, 2008). This is what is being assessed in the 
context of a full economic evaluation, defi ned as ‘the comparative analysis 
of alternative courses of action in terms of both the costs and consequences’ 
(Drummond et al., 2005).
From an economic perspective, primary benefi ts that may be derived from 
integrated care approaches, in addition to improved health and related 
outcomes as experienced by the service user as the core impacts, include short 
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and long-term cost savings. These may be achieved through, for example, 
avoidance of complications, reduced health-care utilization and health-care 
cost, and labour productivity gains where the working age population is 
concerned, or wider benefi ts achieved through participation in society, reduced 
carer burden, and others (Sepucha, Fowler & Mulley, 2004; Suhrcke, Fahey 
& McKee, 2008; Lewis, 2009). The range of costs and benefi ts derived from 
a given initiative will depend on the perspective taken, such as whether the 
evaluative information is aimed at informing resource allocation decisions 
within a given agency (for example, a health insurer or local health authority), 
within a particular system (for example the health and social care systems), or 
within the wider economy or society (societal perspective) (Knapp, 2007). The 
perspective taken will then determine the range of measures to be considered 
in the economic evaluation, both in terms of costs and benefi ts.
One of the key challenges to assessing the economic impact (or indeed 
‘intervention’ effect more generally) of complex interventions such as integrated 
care approaches is the requirement of a controlled design or robust comparison 
strategy to isolate effects that can be attributed to the intervention from those 
that would have occurred without it (the counterfactual) (Craig et al., 2008). 
Thus, full economic evaluations such as cost–effectiveness analysis (CEA), cost–
utility analysis (CUA) and cost–benefi t analysis (CBA) require the presence of an 
alternative strategy – typically, usual care – to enable assessment of costs and 
benefi ts of a given intervention (Table 1) (Villalba van Dijk et al., 2012).
Table 1 Types of economic analysis
Type of analysis Description
Cost–offset study, cost analysis Compares costs incurred with (other) costs saved; does not 
consider alternative use of resources elsewhere 
Cost-minimization analysis As cost analysis but compares two or more interventions or 
programmes; assumes outcomes of different programmes to 
be broadly equivalent
Cost–consequence analysis 
(CCA)
Compares the costs and consequences of two or more 
alternatives, but does not aggregate or synthesize costs and 
consequences, and all health outcomes are left in natural units
Cost–effectiveness analysis 
(CEA)
Relates costs to a (typically single) common outcome between 
alternative interventions/programmes (which can also involve 
no intervention)
Cost–utility analysis (CUA) Relates costs to utilities as a measure of programme effect; 
results of CUA are typically expressed in terms of cost per 
health year of cost per QALY gained 
Cost–benefi t analysis (CBA) Economic evaluation that values all costs and benefi ts in the 
same (monetary) value; results of CBA are typically expressed 
as a ratio of costs to benefi ts or a sum representing the net 
benefi t (or loss) of one programme over another
Source: Adapted from Drummond et al. (2005) and Kelly et al. (2005).
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Cost–effectiveness and cost–utility analysis are the most commonly used 
methods in health-care economic evaluations. They express the benefi ts of 
a given intervention in terms of natural units (cost–effectiveness), such as 
life years gained, reduction in blood pressure, or in a synthetic overall health 
measure (cost–utility), such as quality adjusted life years (QALYs), assuming 
that the core benefi ts of the intervention occur exclusively or primarily in health 
terms. By contrast, cost–benefi t analyses (CBA) adopt a societal perspective and 
seek to place a monetary value on all (measurable) costs and benefi ts.
Other forms of economic analysis, frequently not referred to as ‘economic 
evaluation’, focus only on the appraisal of costs, with the range of costs 
determined by the perspective taken. Such an analysis is typically chosen when 
outcomes of a given intervention are either already established or are not (yet) 
measurable (Kelly et al., 2005). Examples include the cost–offset study, which 
compares costs incurred with (other) costs saved. It does not consider other 
approaches or alternative use of resources, which is typically the subject of cost-
minimization analyses (see Table 1).
As noted above, one core challenge in undertaking a full economic evaluation 
is the need to identify a comparison strategy. Other challenges include 
consideration of the types of cost that may be relevant, the data sources 
that can provide information appropriate to such measures and the availability 
of actual data to enable cost estimation. Costing methodology generally 
distinguishes direct, indirect and intangible costs, although these have been 
conceptualized in different ways (Johnston et al., 1999). Direct costs typically 
refer to costs of health-care services as they relate to the prevention, diagnosis 
and treatment of a given condition, such as inpatient or outpatient care, 
rehabilitation, community health services and pharmaceuticals; direct costs may 
also include social care costs where relevant (Suhrcke, Fahey & McKee, 2008). 
Indirect costs typically refer to productivity losses to society because of ill 
health or its treatment, or more broadly the resources lost due to any condition 
or disease that might have occurred in the absence of the intervention 
(Koopmanschap et al., 1995). Intangible costs generally describe the psychological 
burden placed on patients and their carers including pain, bereavement, anxiety 
and suffering (Knapp, 2007; Suhrcke, Fahey & McKee, 2008).
It is important to consider that a given intervention may be found to be 
cost-effective but not necessarily cost saving. This will for example be the 
case where a given intervention that was found to be cost-effective identifi es 
substantial unmet need and so, at least in the short to medium-term, increases 
costs associated with meeting this need. In addition, where cost savings 
are considered as an outcome measure, there is a need to ensure complete 
accounting of all relevant costs, that is direct and indirect health and non-
health-care costs as described above. For example, in the fi eld of disease 
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management, existing evaluations tend to focus on actual expenditure incurred 
by the funder of the intervention (for example, health insurer) (Linden & 
Adams, 2007). Yet, especially in the context of initiatives that seek to integrate 
care across providers, it will be important to adopt a broader view, in particular 
where costs are dispersed across health and social services (Vondeling, 2004). 
At the same time, indirect impact on, for example productivity among those 
receiving the intervention, might be less relevant where integrated care 
activities target older populations, while impact on their informal caregivers in 
terms of, for example loss of income as they cannot work, may be important 
(Bolin, Lindgren & Lundborg, 2008; Lilly, Laporte & Coyte, 2010).
4 Methods
The rapid evidence review presented here principally follows the approach 
by Ouwens et al. (2005) who presented a review of systematic reviews of the 
effectiveness of integrated care programmes for the chronically ill. Extending 
this approach, our review focuses on economic impacts of integrated 
care approaches. 
We undertook a limited search of PubMed, the National Library of Medicine’s 
Medline and pre-Medline database, Embase and the Cochrane Library. We 
identifi ed studies using medical subject headings (MeSH) or the Embase 
equivalent Emtree (Elsevier’s Life Science Thesaurus) with the following 
headings (‘/’ indicating ‘or’): ‘Delivery of health care, integrated/regional health 
planning/patient care management/ disease management’ in combination with 
‘Cost control/costs and cost analysis/effi ciency/cost–benefi t analysis/patient 
admission’. We limited our search to studies classifi ed as systematic review 
or meta-analysis that were published from 2004 onwards, as the review by 
Ouwens et al. (2005) covered systematic reviews and meta-analyses published 
from 1996 to May 2004.
We included reviews of original studies that focused on integrated care 
approaches, chronic care interventions and disease management programmes 
but excluded those that examined single interventions only, such as patient 
education, physician education or nurse-led counselling. However, we did 
consider case management approaches where these involved linking two or 
more different providers (for example, planned hospital discharge). We did 
not formally assess the quality of reviews but excluded those that did not 
explicitly state the search strategy, inclusion and exclusion criteria, the analytical 
approach taken or did not describe whether studies were assessed for quality.
Studies were analysed using a data extraction template, describing information 
on the study design, the stated defi nition of the integrated care intervention/s 
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under review, and the core outcomes considered. We distinguished three basic 
cost outcomes, which we conceptualized as follows: 
• Utilization: the level of use of a particular service over time, such as 
physician visits; emergency room/accident and emergency department (ED) 
visits; hospital (re-) admissions; length of hospital stay; hospital days;
• Cost–effectiveness: benefi ts of the intervention in terms of natural units 
(cost–effectiveness), such as life years gained, reduction in blood pressure, 
or in a synthetic overall health measure (cost–utility), such as quality 
adjusted life years (QALYs);
• Cost and/or expenditure:
 cost: cost of providing a particular service (health, nursing, social 
care), including the costs of procedures, therapies, and medications 
where applicable;
 expenditure: amount of money paid for the services, and from fees, 
which refers to the amount charged, regardless of cost;
 avoided cost: costs caused by a health problem or illness which are 
avoided by a given intervention.
 We recognise that the terms ‘cost’ and ‘expenditure’ are conceptually 
different; however, most studies reviewed here used these terms 
interchangeably and we therefore considered these together. 
For completeness, we also extracted data on core health outcomes such as 
health status, quality of life and mortality, as well as process measures. The 
effect of the intervention was summarized by statistical signifi cance: was there 
a positive (or negative) trend in the majority of studies reviewed or was no 
statistically signifi cant effect or trend observed? 
5 Findings
Our search identifi ed a total of 963 references across the three databases, and 
after removal of duplicates, we accepted 70 references for further screening. 
Of these, 19 articles were identifi ed as eligible for inclusion. There were eleven 
systematic reviews (Gilbody, Bower & Whitty, 2006; Chiu & Newcomer, 2007; 
Smith & Newton, 2007; Brink-Huis, van Achterberg & Schoonhoven, 2008; 
Maciejewski, Chen & Au, 2009; Steuten et al., 2009; Pimouguet et al., 2010; 
van Steenbergen-Weijenburg et al., 2010; Althaus et el., 2011; de Bruin 
et el., 2011; Smith et al., 2012b), six systematic reviews and meta-analyses 
(Neumeyer-Gromen et el., 2004; Phillips et al., 2004; Langhorne et al., 2005; 
Shepperd et al., 2008; Steffen et al., 2009; Tappenden et al., 2012) and two 
studies not explicitly labelled as systematic reviews but which were included 
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as they met our basic criteria (Oeseburg et al., 2009; Simoens et al., 2011). 
Two studies (Shepperd et al., 2009; Smith et al., 2012a) identifi ed by our search 
were based on Cochrane reviews and we therefore retrieved and included the 
relevant full review for further assessment (Shepperd et al., 2008; Smith et al., 
2012b). One further review identifi ed by our search (Langhorne & Holmqvist, 
2007) presented an update of an earlier meta-analysis that comprised the full 
set of economic outcomes assessed in that review (Langhorne et al., 2005); for 
this reason, we included the earlier review only. Two recent reviews considered 
of potential relevance had to be excluded as they were available in abstract 
format only, with the full review yet to published (Boland et al., 2012; Goossens 
et al., 2012).
Table 2 provides an overview of the key characteristics and evidence of effect of 
integrated care approaches identifi ed.
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Table 2 Key characteristics and evidence of integrated care approaches
Study Design (number 
of studies)
Condition(s) 
or populations 
targeted
Defi nition 
integrated care 
(number of studies)
Outcome measures                      
(number of studies)                     
Functional 
status and 
clinical 
outcomes
Quality 
of life
Althaus et al. 
(2011)
Systematic review 
(n=11 studies: 
3 randomized 
controlled trials, 
8 before–after 
studies of which 
6 without control)
Frequent 
hospital 
ED users
No explicit defi nition
Most interventions 
reviewed involved 
case management (7), 
involving coordination 
of multi disciplinary 
care by case manager; 
locus of intervention 
generally not limited 
to the hospital, often 
extending to the 
community
Reduced alcohol 
and drug use 
(2/3 studies) 
and signifi cantly 
decreased social 
problems (3) 
N/R
Brink-Huis 
et al. (2008)
Systematic review 
(n=12 studies: 2 
quasi-experimental, 
5 before–after 
without control, 
3 observational; 
2 studies classifi ed 
as ‘expert opinion’ 
of low quality 
evidence)
Pain (adult 
cancer patients)
Organizational 
models integrating 
processes 
Distinguished 3 types:
1. Institutionalization 
of pain management 
strategies (principles 
and activities 
incorporated into 
patterns of daily 
practice) (3)
2. Clinical pathways 
(focus on pain 
assessment and 
treatment; 
interdisciplinary 
approach; continuity 
of care) (4)
3. Pain consultation 
(‘tailor made’; 
interdisciplinary 
approach; care 
coordination at core) 
(5)
Pain intensity 
and pain relief:
Clinical pathway 
and pain 
consultation 
models showed 
signifi cant 
decrease in pain 
intensity and 
improvements 
in pain relief (5) 
Institutionali-
zation models 
showed no 
signifi cant 
improvement (1) 
N/R
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                       Outcome measures
                       (number of studies)
Cost measures (number of studies)
Patient 
satisfaction
Mortality Process Utilization Cost–effectiveness Cost/expenditure
No change 
(1)
Inconclusive 
(1)
N/R Reduction in ED 
visits (1/3 RCTs; 
6 before–after); 
although 
signifi cant 
increase in 1
Inconclusive 
evidence for 
use of other 
health services 
(e.g. admissions, 
hospital days, 
outpatient visits)
Report of cost–
effectiveness of 
intervention in 
1 RCT on basis of 
improved clinical 
and social outcomes 
at similar cost to 
usual care (not 
quantifi ed);
Perspective: hospital
Signifi cant reduction 
in ED costs (3)
Median reduction 
per patient of $2406 
after intervention 
(from $21 022 to 
$14 910) for all 
hospital services 
costs and median 
reduction in ED 
costs per patient of 
$1938 from $4124 
to $2195 reported in 
1 before–after study
Perspective in all 
3 studies: hospital
Satisfaction 
with pain 
manage-
ment: 
Some 
evidence of 
increased 
patient 
satisfaction 
within 
institution-
alization 
and clinical 
pathway 
models (2) 
N/R Improve-
ments in pain 
assessment 
(2) and pain 
treatment (3) 
Reduction in 
unscheduled 
readmissions for 
uncontrolled pain 
from 4.4–4% in 
one year (1) 
N/R Reduction in 
hospital cost by 
$2mln (1)
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Study Design (number 
of studies)
Condition(s) 
or populations 
targeted
Defi nition 
integrated care 
(number of studies)
Outcome measures                      
(number of studies)                     
Functional 
status and 
clinical 
outcomes
Quality 
of life
Chiu & 
Newcomer 
(2007)
Systematic 
review (n=15 
studies reported 
in 16 articles; 
14 RCTs, 1 quasi-
experimental 
study)
Older patients 
requiring 
discharge from 
hospital to 
other settings
Nurse-assisted 
interventions 
intended to improve 
transition of older 
patients from 
hospitals to other 
settings (excluded 
psychiatric patients)
Common elements 
included home 
visits and telephone 
contact, about 
one-third of 
interventions studied 
involved liaison and 
coordination with the 
patient’s physician 
and other care 
providers
N/R N/R
de Bruin et al. 
(2011)
Systematic review 
(n=31 studies: 
18 RCTs, 3 quasi-
experimental, 
3 cross-sectional, 
2 descriptive, 
2 before–after, 
2 prospective 
observational 
studies, 
1 longitudinal 
analysis of 
paid claims)
Diabetes (14), 
depression (4), 
heart failure 
(8), COPD (5)
Interventions that 
contained two or 
more components 
of the CCM (self-
management support, 
delivery system 
design, decision 
support, clinical 
information system, 
health-care system, 
community resources 
and policies)
N/R N/R
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                       Outcome measures
                       (number of studies)
Cost measures (number of studies)
Patient 
satisfaction
Mortality Process Utilization Cost–effectiveness Cost/expenditure
N/R No change 
(2)
N/R Unplanned 
readmissions: 
No signifi cant 
difference (7), 
signifi cantly fewer 
readmissions (8), 
up to 1/3 fewer 
(measured up to 
6 months post 
discharge)
Hospital days: 
Signifi cant 
reductions in the 
number of hospital 
days or length of 
stay (7) 
ED visits: 
Limited evidence 
of reduction (3)
N/R Hospital 
expenditure 
signifi cantly reduced 
with intervention (6)
Limited evidence 
from studies of 
heart failure care of 
reduced total cost 
or hospital cost and 
intervention cost (3)
N/R N/R N/R Diabetes: 
Inconclusive 
evidence of 
impact on health-
care utilization 
(hospitalizations, 
physician visits, 
inpatient days) (14)
Depression: 
no signifi cant 
difference in 
utilization (1)
Heart failure: 
signifi cant 
reduction in 
hospitalization (3) 
and ED visits (2). 
Less conclusive 
evidence on (re)
admission (2)
COPD: Signifi cant 
reduction in (re)
admission (2/3), 
hospitalization (1) 
and ED visits (1). 
Less conclusive 
evidence on length 
of stay (1/2)
Incremental cost per 
QALY:
$34 248–69 027 per 
QALY (1) (diabetes) 
$2518–66 686 
per QALY (1) 
(depression)
$17 747–156 655 
per QALY (2) (heart 
failure)
N/R (COPD) 
Avoided health-care 
cost:
$5200 per patient 
(1) (diabetes) 
Incremental health-
care cost per patient 
per year ranged 
from: 
$3305 to $16 996 
(all disease groups) 
$828 to $2533 
(diabetes) 
$589 to $863 
(depression) 
$3305 to $4970 
(heart failure) 
$9 to $16,996 
(COPD) 
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Study Design (number 
of studies)
Condition(s) 
or populations 
targeted
Defi nition 
integrated care 
(number of studies)
Outcome measures                      
(number of studies)                     
Functional 
status and 
clinical 
outcomes
Quality 
of life
Gilbody et al. 
(2006)
Systematic review 
of economic 
evaluations (n = 11 
cost–effectiveness 
studies of RCTs) 
Depression Enhanced primary 
care that could 
include range of 
organizational 
interventions 
Majority of studies set 
in the US (9/10); 6 (US) 
involved collaborative 
care models linking 
primary and specialist 
care, frequently 
including non-medical 
care coordinator 
such as social worker, 
mental health worker, 
psychologist
Signifi cant 
improvement 
in SCL score (5) 
although not 
always sustained 
(1)
Incon clusive 
evidence on 
HRQoL (4)
Langhorne 
et al. (2005)
Systematic review 
and meta-analysis 
(n = 12 RCTs, 1659 
patients included 
in meta-analysis)
Stroke ESD – defi ned as 
services that aim to 
accelerate patient’s 
discharge home and 
provide an equivalent 
level of rehabilitation 
input in the patient’s 
own home as in 
conventional hospital 
care and discharge 
arrangements. In 
7/12 trials, a single 
multidisciplinary ESD 
team co-ordinated 
hospital discharge 
and provided 
rehabilitation at home 
E/R No 
signifi cant 
difference 
for 
subjective 
health 
status or 
mood for 
carers or 
patients 
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                       Outcome measures
                       (number of studies)
Cost measures (number of studies)
Patient 
satisfaction
Mortality Process Utilization Cost–effectiveness Cost/expenditure
Increased (3) N/R Signifi cant 
improve-
ments in 
adequacy 
of anti-
depressant 
dosage 
(5) and 
concordance 
(2)
N/R Enhanced care 
programmes for 
newly diagnosed 
depression: 
Cost per depression 
free day £7–13 (2)
Cost per QALY 
ranged from 
£8190 to £19 483 
depending on 
intervention 
and method of 
calculating QALYs. 
Enhanced care for 
treatment-resistant 
depression: 
£19 per depression 
free day (total 
health-care cost) 
Enhanced care to 
prevent relapse 
in recurrent 
depression: 
£0.5 per depression-
free day (total 
health-care costs) 
but little signifi cant 
confi dence 
N/R
Increased 
satisfaction 
among 
patients
No 
signifi cant 
difference 
among 
carers
Those 
receiving 
ESD 
signifi cantly 
less likely to 
be dead or 
dependent 
(median 
6-month 
follow-up)
No 
signifi cant 
difference 
for mortality 
alone 
N/R Length of hospital 
stay signifi cantly 
reduced, on 
average by 8 days
No signifi cant 
difference in 
readmission rates 
N/R Potential cost 
savings reported (5). 
Median 20%, range 
4–30%
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Study Design (number 
of studies)
Condition(s) 
or populations 
targeted
Defi nition 
integrated care 
(number of studies)
Outcome measures                      
(number of studies)                     
Functional 
status and 
clinical 
outcomes
Quality 
of life
Maciejewski 
et al. (2009)
Systematic review 
(n=29 studies based 
on 27 studies: 
5 RCTs, 7 before–
after with control, 
3 after-only with 
control, 12 before–
after without 
control) 
Asthma Disease management 
(excluded solely 
patient education or 
self-management). 
All interventions had 
multiple components 
Clinical 
outcomes 
(symptoms, 
peak expiratory 
fl ow, forced 
expiratory 
volume)
Limited evidence 
from RCTs of 
signifi cant effect 
(3/8 assessments) 
Asthma-
related 
quality of 
life, days 
off work/
school 
Very limited 
evidence 
from RCTs 
of effect 
on patient-
reported 
outcomes 
(2/12) 
Neumeyer-
Gromen 
et al. (2004)
Systematic review 
and meta-analysis 
(n=10 RCTs)
Meta-analysis 
included: 
3928 patients, 
10 RCTs for 
depression severity; 
1077 patients, 
4 RCTs for patient 
satisfaction; 
3618 patients, 
8 RCTs for 
adherence to 
treatment)
Depression 
(adults aged 
18+)
No explicit defi nition
‘Complete DMP’ 
comprising use of 
evidence-based 
guidelines, patient 
self-management 
education, 
provider education, 
collaborative care, 
reminder systems, 
monitoring 
Signifi cant 
improvement: 
depression 
severity (10)
Signifi cant 
improve-
ment (4)
Oeseburg 
et al. (2009)
Literature review 
(n=9 RCTs)
Case 
management 
for chronic 
illness (elderly, 
frail)
Not stated but eligible 
studies analysed 
patient advocacy case 
management model 
and evaluated service 
use and costs 
N/R N/R
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                       Outcome measures
                       (number of studies)
Cost measures (number of studies)
Patient 
satisfaction
Mortality Process Utilization Cost–effectiveness Cost/expenditure
N/R N/R Measures 
included: 
inhaler 
technique, 
use of peak-
fl ow metre, 
use of action 
plan
ED visits, 
hospitalization:
Limited evidence 
from RCTs of effect 
on economic 
outcomes 
(6/17 assessments) 
although nature 
of economic effect 
not specifi ed
N/R N/R
Signifi cant 
improve-
ment (4)
N/R Signifi cant 
improvement: 
adherence to 
treatment (4)
N/R Lower incremental 
cost per successfully 
treated case 
compared to 
usual care 
Cost utility ratios 
ranged between 
$9051 and $49 500 
per QALY
DMP associated with 
increased costs in 
comparison to usual 
care
Some evidence of 
cost offset – lower 
cost per successfully 
treated patient in 
intervention (2)
N/R N/R N/R Inconclusive 
evidence on 
hospital admissions 
reporting increases 
(1) and decreases 
(1) 
Limited evidence of 
reduction in length 
of stay (1)
Clinically relevant 
reduction in ED 
visits (1)
No effect on 
nursing home 
admissions (3)
N/R Inconclusive 
evidence: savings 
from decrease in 
nursing home, 
hospital and 
community health 
service costs (1); 
increased costs (not 
signifi cant) reported 
in one other study
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Study Design (number 
of studies)
Condition(s) 
or populations 
targeted
Defi nition 
integrated care 
(number of studies)
Outcome measures                      
(number of studies)                     
Functional 
status and 
clinical 
outcomes
Quality 
of life
Phillips et al. 
(2004)
Systematic review 
and meta-analysis 
(n=19 reports of 
18 RCTs, n = 3304 
patients for meta-
analysis)
Congestive 
heart failure 
(older people, 
mean age >55)
Comprehensive 
discharge planning 
plus post-discharge 
support for older 
inpatients
N/R Signifi cant 
improve-
ment in 
quality of 
life scores 
of inter-
vention 
patients (6)
Pimouguet 
et al. (2010) 
Systematic review 
(n=13 studies, 
based on 12 RCTs)
Dementia Case management 
as ‘any intervention 
involving interaction 
between a case 
manager and patient–
caregiver dyads and 
providing continuity 
and advocacy over 
time, support, 
information about 
community services, 
care and disease 
evolution, fi nancial 
and legal advices’ 
N/R N/R
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                       Outcome measures
                       (number of studies)
Cost measures (number of studies)
Patient 
satisfaction
Mortality Process Utilization Cost–effectiveness Cost/expenditure
N/R Trend 
towards 
lower 
all-cause 
mortality 
(14)
N/R Signifi cantly fewer 
readmissions or 
cause-specifi c 
readmissions 
(pooled data 
from18 studies)
Non-signifi cant 
reduction in length 
of stay (10)
N/R Pooled cost 
difference favoured 
intervention 
patients -$359 in 
non-US trials and 
-$536 in US trials
Average cost of 
treatment $80.76 
per patient per 
month for trials in 
US and $55.76 per 
patient per month 
in non-US trials
N/R N/R N/R Delay in nursing 
home admission 
with intervention 
(3)
Nursing home 
admission rate: 
reduction (2), 
no change (2) 
No signifi cant 
effect on 
hospitalization rate 
or emergency room 
visits (6)
N/R No difference in 
cost (3)
One estimate of 
saving of $90 000 
for 1.5 days delay 
in nursing home 
admission (1) 
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Study Design (number 
of studies)
Condition(s) 
or populations 
targeted
Defi nition 
integrated care 
(number of studies)
Outcome measures                      
(number of studies)                     
Functional 
status and 
clinical 
outcomes
Quality 
of life
Shepperd 
et al. (2008)
Systematic review 
and meta-analysis 
(10 RCTs; n=850 
individual patients 
from 5 RCTs for 
meta-analysis)
Patients aged 
18 years and 
over
‘Hospital at home’ 
defi ned as ‘a service 
that can avoid the 
need for hospital 
admission by 
providing active 
treatment by health 
care professionals in 
the patient’s home 
for a condition that 
otherwise would 
require acute hospital 
in-patient care, and 
always for a limited 
time period. In 
particular, hospital 
at home has to offer 
a specifi c service to 
patients in their home 
requiring health-care 
professionals to take 
an active part in the 
patients’ care’
Non-signifi cant 
differences in 
functional ability 
on a variety of 
measures (5)
Reduction in 
problems with 
sleep, agitation 
and aggression, 
and feeding 
among patients 
with dementia 
in one study
Mixed evidence 
on cognitive 
function and 
psychological 
well-being (5)
Fewer patients 
reported bowel 
or urinary 
complications (1) 
Mixed evidence 
on range of 
other clinical 
outcomes
Non-
signifi cant 
differences 
in quality 
of life 
measures 
(SF36) (3)
Simoens et al. 
(2011)
Review (n=8 
studies, 7 reporting 
outcomes, 6 cost–
effectiveness 
analyses, 1 cost 
utility analysis and 
1 study using cost–
effectiveness and 
cost–utility analysis) 
Patients in 
transition 
between 
ambulatory 
care (including 
nursing homes) 
and hospital 
care
No explicit defi nition
Medication 
management as 
a component of 
seamless care defi ned 
as, ‘the continuity of 
care delivered to the 
patient in the health 
care system across 
the spectrum of care 
givers and health care 
settings’. 
Limited evidence 
No difference 
in anxiety 
symptoms, 
depressive 
symptoms, 
somatic 
symptoms or 
number of side-
effects for study 
of medication 
error among 
patients with 
major depressive 
episode
Limited 
evidence 
No 
difference 
in QoL (1) 
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                       Outcome measures
                       (number of studies)
Cost measures (number of studies)
Patient 
satisfaction
Mortality Process Utilization Cost–effectiveness Cost/expenditure
Signifi cantly 
higher levels 
across a 
range of 
conditions 
(4)
Signifi cant 
reduction in 
mortality at 
six months 
follow-up
No signifi cant 
difference 
in GP’s 
satisfaction 
with service 
(1)
Mixed 
signifi cant 
(1) and non-
signifi cant 
(2) risk of 
living in an 
institutional 
setting
Non-signifi cant 
increase in 
admissions (pooled 
across 5 studies)
Mixed evidence, 
with increases 
and decreases in 
hospital length 
of stay
Increased referrals 
for social support 
for COPD patients 
(1) and increased 
use of informal 
care for those 
recovering from 
stroke (1)
N/R Medical condition
Mean difference in 
cost per day ranged 
from -$293 to 
£72.98 (2) 
Stroke
Limited evidence of 
signifi cant reduction 
in cost per day 
($163.0 vs $275.6)
COPD and 
community-acquired 
pneumonia
Signifi cantly 
reduced costs per 
patient, NZ$ 398.4 
(1) and per bed day, 
-£1798, (1)
Limited 
evidence of 
impact on 
satisfaction 
Higher 
satisfaction 
among 
patients 
receiving 
phone call 
(1) and 
for those 
receiving 
counselling 
at home (1)
Limited 
evidence 
Some 
evidence 
that 
extensive 
medication 
review 
and drug 
counselling 
had no 
impact on 
mortality (1) 
Mixed 
evidence on 
medication 
adherence: 
improved (2), 
no difference 
(1) 
Fewer hospital 
admissions (3), 
ED visits (1) and 
length of stay (1) 
Some evidence of 
higher primary care 
follow-up rate (1) 
Limited evidence 
Pharmacist-led 
reconciliation 
in prevention 
of medication, 
€13 000 per QALY 
(1) 
Evidence of savings 
associated with 
prevention or 
reduction in hospital 
utilization (ranging 
from €109 to €699 
saving per patient 
Limited evidence 
of reduction in 
medication costs 
(€20.7)
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Study Design (number 
of studies)
Condition(s) 
or populations 
targeted
Defi nition 
integrated care 
(number of studies)
Outcome measures                      
(number of studies)                     
Functional 
status and 
clinical 
outcomes
Quality 
of life
Smith & 
Newton (2007)
Systematic review 
(n=60 studies: 
39 analytic, 
21 descriptive)
Mental illness/
psychiatry 
Case management
The majority of 
studies assessed 
ACT or ICM (55)
Symptoms 
(not specifi ed): 
no change (5), 
decreased (1)
Social function: 
Mixed evidence: 
increased (2), no 
change (3)
Mixed 
evidence: 
increased 
(3), no 
change (3)
Smith et al. 
(2012b)
Systematic review 
(n=6 RCTs)1
People or 
populations 
with co-
existence 
of two or 
more chronic 
conditions
No explicit defi nition
Interventions 
designed to improve 
outcomes in patients 
with multimorbidity 
in primary care and 
community care 
settings. Focused 
on ‘organizational 
interventions’, which 
were predominantly 
case management, 
care coordination or 
enhancement of skill 
mix in interdisciplinary 
teams
Mixed evidence 
of signifi cant 
result on 
physical health 
outcomes. Some 
signifi cant 
improvement 
in blood 
pressure (2), 
mixed evidence 
of impact 
on HBA1c in 
the case of 
diabetes (2). 
No signifi cant 
improvement in 
patient reported 
outcomes, 
e.g. pain, 
energy, 
shortness of 
breath, symptom 
scores (2)
Mental health: 
signifi cant 
improvements in 
depression (2/3) 
but not in one 
other study
Mixed 
evidence on 
psycho social 
outcomes
One out of 
4 studies 
reported 
statistically 
signifi cant 
improve-
ment 
HEQoL 
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                       Outcome measures
                       (number of studies)
Cost measures (number of studies)
Patient 
satisfaction
Mortality Process Utilization Cost–effectiveness Cost/expenditure
Increased (3), 
no change 
(1) 
Limited 
evidence of 
no change 
(1)
Adherence: 
Increase (1)
Number of 
admissions: 
mixed evidence: 
decreased (2), 
no change (3), 
increased (1)
Admission days: 
mixed evidence: 
decreased (4), 
no change (3), 
increased (2) 
N/R Limited and mixed 
evidence: costs 
decreased (1), cost 
no change (1)
Costs not specifi ed 
Limited 
evidence of 
improved 
satisfaction 
with 
treatment 
and service 
provision (2)
Limited 
evidence on 
mortality
One study 
reported 
and showed 
reduced 
mortality 
among 
inter vention 
group
Limited 
evidence of 
impact on 
medication 
use and 
adherence: 
signifi cant 
improve-
ment anti-
depressant 
and anti-
hyper tension 
medication 
adherence (1)
Evidence of 
improve-
ments in 
provider 
behaviour 
–patient 
measure of 
quality of 
care, chronic 
disease 
manage-
ment score, 
preventive 
care score, 
prescribing 
(3) 
Mixed evidence on 
health service use 
Signifi cant 
improvements in 
number of hospital 
admissions and 
length of stay (2), 
no signifi cant 
difference in 
admission related 
outcomes (4) 
N/R Limited evidence of 
cost savings among 
programmes with 
improved outcomes 
for patients (2)
$90 per intervention 
patient for a 
SeniorCareConnect-
ions intervention 
(excludes costs 
of implementing 
intervention 
and additional 
savings from fewer 
physician visits) 
Very limited 
evidence on 
expenditure. 
Mean medical 
costs relating 
to TeamCare 
intervention 
reported to be 
$1224 per patient 
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Study Design (number 
of studies)
Condition(s) 
or populations 
targeted
Defi nition 
integrated care 
(number of studies)
Outcome measures                      
(number of studies)                     
Functional 
status and 
clinical 
outcomes
Quality 
of life
Steffen et al 
(2009)
Systematic review 
and meta-analysis 
(n=11: 6 RCTs, 
3 controlled clinical 
trials, 2 cohort 
studies)
Adult (>18 
years) patients 
in mental 
health care 
Discharge planning, 
defi ned as 
‘multifaceted or 
single interventions 
established prior to 
hospital discharge, 
involving personal 
contact between 
the patient and 
hospital staff, aiming 
at preventing, 
facilitating or solving 
anticipated problems 
in subsequent 
outpatient care’ 
Six studies focused on 
patient education and 
communication. The 
remainder included 
management/
coordination (2), 
transitional discharge 
model (2), pre-
discharge planning (1)
Evidence of 
improvement in 
mental health 
status (4), 
pooled effect 
size signifi cant 
Limited and 
incon clusive 
evidence of 
improved 
QoL (4), 
pooled 
effect 
size not 
signifi cant
Steuten et al. 
(2009)
Systematic review 
(n=20 studies on 
17 interventions) 
Adults with 
mild, moderate, 
severe or very 
severe COPD
Programmes 
consisting of 
more than one 
component of 
disease management 
as defi ned by the 
DMAA or CCM
Evidence of 
limited impact 
on outcomes 
(lung function, 
dyspnoea, 
physical 
functioning 
and mental 
functioning) 
Limited evidence 
of improved 
lung function 
(2), physical 
functioning 
(3) and mental 
functioning (3)
Evidence of 
short-term 
improve-
ment in 
HRQoL but 
evidence 
of no 
difference 
at 12 month 
follow-up 
(16)
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                       Outcome measures
                       (number of studies)
Cost measures (number of studies)
Patient 
satisfaction
Mortality Process Utilization Cost–effectiveness Cost/expenditure
N/R Probability 
of adherence 
25% greater 
in inter-
vention 
group but 
high hetero-
geneity
N/R Relative risk of 
reduction in 
readmission rates 
was 35% in favour 
of intervention
N/R Non-signifi cant 
reduction in costs 
associated with 
reduction in hospital 
and emergency 
room services (1)
N/R Relative risk 
of mortality 
ranged from 
0.31 to 1.20 
with inter-
vention but 
none were 
statistically 
signifi cant 
(14) 
Limited 
impact on 
prescribing 
patterns (4) 
Signifi cant 
increase 
in patient 
education (5)
Relative risk of 
hospitalization 
varied from 0.64 
to 1.5
Relative risk of 
ED visits ranged 
from 0.28 to 2.28, 
both favouring 
the intervention 
Evidence of limited 
impact on GP, 
specialist or nurse 
visits (6) Limited 
evidence of greater 
utilization (2)
Based on changes 
in HRQoL and 
survival, a societal 
WTP of €30 000 
per QALY would 
mean programme 
cost-effective if 
incremental cost 
does not exceed 
€7680 per patient 
over his/her lifetime 
(6.7 years) (1 study)
No studies reported 
signifi cant savings 
in costs 
Some evidence 
that programmes 
would have to be 
cost-saving to be 
cost-effective
One study reported 
reduced prescription 
costs associated with 
intervention
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Study Design (number 
of studies)
Condition(s) 
or populations 
targeted
Defi nition 
integrated care 
(number of studies)
Outcome measures                      
(number of studies)                     
Functional 
status and 
clinical 
outcomes
Quality 
of life
Tappenden 
et al. (2012)
Systematic 
review of clinical 
effectiveness 
(n=11), Meta-
analysis (8 studies) 
and systematic 
review of cost–
effectiveness (3) 
Older people 
(>75 years) 
at risk of 
admission 
to hospital, 
residential or 
nursing care 
Structured home-
based, nurse-led 
health promotion 
Interventions included 
treatment and other 
related activities
Considerable 
heterogeneity 
in interventions; 
6 involved nurse/
health visitor-led 
care management, 
liaison with other 
health and social-care 
professionals and care 
coordination 
Trend of non-
signifi cant 
reduced number 
of falls in 
intervention 
group (pooled 
estimate)
Limited evidence 
of greater 
independence 
in intervention 
group (2) but 
further evidence 
inconclusive (2)
Limited (1) 
and non-
signifi cant 
evidence of 
impact on 
QoL
van 
Steenbergen-
Weijenburg 
et al (2010)
Systematic review 
(n=8; 4 cost–
effectiveness 
analysis; 4 cost–
effectiveness and 
cost–utility analysis) 
Patients 
diagnosed 
with major 
depressive 
disorder
‘Collaborative care’, 
defi ned as having 
meeting at least 3 of 
following criteria: 
1. Include role of care 
manager
2. Network formed 
around patient of at 
least 2 or 3 different 
professionals
3. Process and 
outcome of treatment 
monitored
4. Evidence-base 
treatment provided 
interventions 
including coordinated/
collaborative care (5), 
conjunction between 
primary and 
secondary care (1)
Reduction in 
depression-free 
days measured 
through 
Hamilton Rating 
Scale (4) and 
SCL (2)
Statistically 
signifi cant 
improvement 
not always 
maintained 
over time (1)
Evidence 
that colla-
borative 
care more 
effective 
than usual 
care (4)
1 This study also reported on four ‘patient-oriented’ interventions, which we have excluded 
as they are largely patient education and not relevant for this review.
Notes: N/R: not reported; RCT: randomized controlled trial; CCM: chronic care model; 
SCL: symptom checklist; HRQoL: health-related quality of life; QALY: quality-adjusted life year; 
ED: emergency department; ESD: early supported discharge; ACT: assertive community 
treatment; ICM: intensive case management; COPD: chronic obstructive pulmonary disease; 
DMAA: Disease Management Association of America; WTP: willingness to pay.
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                       Outcome measures
                       (number of studies)
Cost measures (number of studies)
Patient 
satisfaction
Mortality Process Utilization Cost–effectiveness Cost/expenditure
N/R Evidence 
that inter-
vention 
signifi cantly 
reduced risk 
of death (8)
N/R Non-signifi cant 
impact on number 
of individuals 
moving into 
residential care (1) 
or admissions to 
hospital (1)
Inconclusive 
evidence from cost–
utility analysis of 
an early discharge 
and rehabilitation 
service compared 
with usual care
High likelihood 
of cost savings 
but little or no 
incremental QALY 
gain (1)
Cost savings of 
approximately 
£600 per patient 
associated with 
early discharge 
and integrated 
care protocols for 
patients admitted to 
hospital with acute 
exacerbations of 
COPD (1)
Cost consequence 
of community-based 
nursing for patients 
with Parkinson’s 
disease showed 
initial cost increase 
while mean increase 
in cost over 2 years 
was £266 lower (1)
N/R N/R N/R N/R Evidence that 
collaborative care 
effective but usually 
more expensive (7) 
Highest cost per 
depression-free 
day $24
Cost–utility studies 
showed cost per 
QALY range from 
$21 478 to $49 500 
(4)
Increment in 
intervention related 
costs (primary direct 
medical cost) ranged 
from $519 to $1,974 
(3) 
Limited evidence 
(1) that travelling 
expenses greater for 
intervention group 
($1636 compared 
to $1337)
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Reviews considered here assessed a wide range of interventions or initiatives 
that targeted a diverse group of people or populations, including:
• older people in the community who were considered frail (Oeseburg 
et al., 2009) or with (long-term) medical or social care needs (Tappenden 
et al., 2012), with specifi c chronic conditions such as heart failure (Phillips 
et al., 2004) or who were about to be discharged from hospital (Chiu & 
Newcomer, 2007);
• frequent users of emergency departments (Althaus et al., 2011), 
hospitalized patients (Simoens et al, 2011) or those about to be 
hospitalized (Shepperd et al., 2008);
• adults with dementia or memory loss (Pimouguet et al., 2010), with severe 
mental health problems (Smith & Newton, 2007) or who received mental 
health care services (Steffen et al., 2009);
• adults with specifi c chronic conditions such as pain (Brink-Huis, 
van Achterberg & Schoonhoven, 2008), depression (Neumeyer-Gromen 
et al., 2004; Gilbody, Bower & Whitty, 2006; van Steenbergen-Weijenburg 
et al., 2010), stroke (Langhorne et al., 2005), asthma (Maciejewski, Chen 
& Au, 2009), COPD (Steuten et al., 2009), diabetes (De Bruin et al, 2011) 
or a combination of these;
• populations with multimorbidity (Smith et al, 2012b).
None of the reviews identifi ed by our searches explicitly defi ned ‘integrated 
care’ as the topic of review. The most common concepts or terms used 
included case management (Smith & Newton, 2007; Oeseburg et al., 2009; 
Pimouguet et al., 2010), care coordination (Langhorne et al., 2005; Chiu & 
Newcomer, 2007), collaborative care (Gilbody, Bower & Whitty, 2006; Brink-
Huis, van Achterberg & Schoonhoven, 2008; van Steenbergen-Weijenburg 
et al., 2010) or a combination of these (Phillips et al., 2004: Shepperd et al., 
2008; Steffen et al., 2009; Althaus et al., 2011; Smith et al., 2012b; Tappenden 
et al., 2012), alongside notions such as interdisciplinary care (Brink-Huis, 
van Achterberg & Schoonhoven, 2008) or seamless care (Simoens et al., 
2011). Four reviews focused on disease management interventions, building 
on multicomponent approaches such as the Chronic Care Model (Neumeyer-
Gromen et al., 2004; Maciejewski, Chen & Au, 2009; Steuten et al., 2009; 
de Bruin et al., 2011).
Initiatives or approaches studied frequently targeted the interface between 
hospital and primary care or community services, most often in the context 
of discharge planning or care transition (Phillips et al., 2004; Langhorne et al., 
2005; Chiu & Newcomer, 2007; Steffen et al., 2009; Althaus et al., 2011; 
Simoens et al., 2011). Several reviews examined initiatives that sought to 
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coordinate primary care and community services, often, although not always, 
involving medical specialists (Gilbody, Bower & Whitty, 2006; Brink-Huis, 
van Achterberg & Schoonhoven, 2008; van Steenbergen-Weijenburg et al., 
2010; Smith et al., 2012b) or extending further into social care services (Smith 
& Newton, 2007; Oeseburg et al., 2009; Pimouguet et al., 2010; Tappenden 
et al., 2012). The latter tended to target older people with multiple care 
needs, those with dementia or with mental health problems. However, it is 
important to note that, typically, reviews considered original studies that were 
set in different health and social care system contexts and which varied in their 
defi nitions of ‘community services’ or ’social care’. Therefore, it will be diffi cult 
to generalize the extent of integration across sectors from different studies.
For those reviews that examined disease management specifi cally it was 
diffi cult to determine the degree to which original studies from individual 
reviews would meet our working defi nition of ‘integrated care’. At the 
same time, as we highlight in Table 2, the majority of reviews included here 
considered a wide range of approaches and only about half of primary studies 
included in individual reviews could be considered ‘integrated care’ in line with 
our working defi nition. 
For example, Althaus et al. (2011) analysed initiatives seeking to reduce 
the number of ED visits by frequent users. Seven of the eleven studies 
reviewed involved some form of case management as a means to coordinate 
multidisciplinary care although the overall nature and scope of interventions 
varied. Similarly, Chiu & Newcomer (2007) examined nurse-assisted interventions 
intended to improve transition of elderly patients from hospital to other settings. 
Interventions varied in scope, with common elements including home visits and 
telephone contact, while one-third of studies involved liaison and coordination 
with the patient’s physician and other care providers. 
Reviews considered a wide range of health and economic outcomes. As noted 
earlier, we included health outcomes for completeness; however in the following 
we comment on economic outcomes only.
5.1 Utilization
Seventeen of the nineteen reviews reported impact on utilization (Phillips 
et al., 2004; Langhorne et al., 2005; Gilbody, Bower & Whitty, 2006; Chiu 
& Newcomer, 2007; Smith & Newton, 2007; Brink-Huis, van Achterberg & 
Schoonhoven, 2008; Shepperd et al., 2008; Maciejewski, Chen & Au, 2009; 
Oeseburg et al., 2009; Steffen et al., 2009; Steuten et al., 2009; Pimouguet 
et al., 2010; Althaus et al., 2011; de Bruin et al., 2011; Simoens et al., 2011; 
Smith et al., 2012b; Tappenden et al., 2012). The majority focused on hospital 
utilization as measured by (re)admission rates, length of stay or number of 
admission days, and ED visits. Impact on nursing home admissions was also 
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reported in two reviews of case management in dementia care (Pimouguet 
et al., 2010) and management of chronic illness among older or frail people 
(Oeseburg et al., 2009). Shepperd et al. (2008), in their systematic review 
of ‘hospital at home’, reported on referrals to social care. The studies that 
did not report on utilization were a review and meta-analysis of disease 
management (Neumeyer-Gromen et al., 2004) and a review and meta-analysis 
of collaborative care (van Steenbergen-Weijenburg et al., 2010), both targeted 
at adults with depression. 
There was inconsistency in reporting on numbers and rates of admissions; 
however, when considered, the studies documented direction and whether or 
not an observed effect was statistically signifi cant. Overall, fi ndings tended to 
be mixed within each review, which makes it diffi cult to draw fi rm conclusions. 
For example, the review by Smith & Newton (2007) found that among six 
studies that analysed hospital admissions, two reported a decrease in the 
number of admissions with case management for mental illness, three reported 
no change and one an increase. However, the authors did not provide any 
further information as to the size of the change, where it occurred or the 
likelihood of observed changes being statistically signifi cant. 
Four meta-analyses pooled patient data (Phillips et al., 2004; Langhorne et al., 
2005; Shepperd et al., 2008) or results across studies for utilization (Steffen 
et el., 2009). Of these, three examined early supported discharge or discharge 
planning and reported on readmission rates. Langhorne et al. (2005) did 
not fi nd evidence of a signifi cant change in readmissions in a study of early 
supported discharge for stroke patients, while Philips et al. (2004), analysing 
data on discharge planning for older people with congestive heart failure, 
reported signifi cantly lower readmission rates compared to usual care (relative 
risk (RR) 0.75; 95% CI 0.64, 0.88) as did Steffen et al. (2009) in their study of 
adult patients in mental health care (readmission to in-patient mental health; 
RR 0.66; 95% CI 0.51, 0.84). Shepperd et al. (2008) analysed studies of a 
‘hospital at home’ service that sought to avoid admission to hospital; however, 
their meta-analysis of patient data pooled from fi ve original studies found a 
non-signifi cant increase in admissions (adjusted hazard ratio (HZ) 1.49; 95% CI 
0.96, 2.33). It may be worth noting that their analysis also showed a signifi cant 
reduction in mortality at six months among those receiving the intervention 
(adjusted HR 0.62; 95% CI 0.45, 0.87). Two meta-analyses also reported 
on length of hospital stay. Philips et al. (2009) were unable to demonstrate 
signifi cant change in length of stay with comprehensive discharge planning 
for congestive heart failure while Langhorne et al. (2005) reported a signifi cant 
reduction in length of hospital stay for early supported discharge for stroke 
patients by, on average, 8 days.
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As indicated above, there was limited evidence on nursing home admissions; 
evidence on case management suggested a benefi cial effect on delaying 
admission to nursing home (Pimouguet et al., 2010) but evidence of impact on 
number of admissions was mixed (Oeseburg et al., 2009: Pimouguet et al., 2010). 
Emergency room visits were commonly reported across systematic reviews (Chiu 
& Newcomer, 2007; Oeseburg et al., 2009; Steuten et al., 2009; Pimouguet 
et al., 2010; Althaus et al., 2011; de Bruin et al., 2011; Simoens et al., 2011). 
Where this measure was considered, the evidence tended to be weak. For 
example, Althaus et al. (2011), analysing interventions specifi cally targeted 
at frequent emergency room (ED) users, reported that only one out of three 
randomized controlled trials identifi ed in their review showed a signifi cant 
reduction in utilization among those receiving the intervention. In contrast, 
six of the eight before–after studies reported a signifi cant reduction in ED 
use and one found a signifi cant increase. However, these fi ndings are diffi cult 
to interpret because they lacked a controlled design. Similarly, Steuten et al. 
(2009), in their review of chronic care programmes for patients with COPD, 
found only limited supportive evidence, reporting six controlled studies of 
which only two showed a signifi cant reduction in ED use among those receiving 
the intervention. Overall, fi ndings were commonly not quantifi ed, making an 
overall assessment of the size of possible effects problematic. 
5.2 Cost–effectiveness
Eight of the nineteen studies reported on cost–effectiveness (Neumeyer-
Gromen et al., 2004; Gilbody, Bower & Whitty, 2006; Steuten et al., 2009; 
van Steenbergen-Weijenburg et al., 2010; Althaus et al., 2011; de Bruin 
et al., 2011; Simoens et al., 2011; Tappenden et al., 2012). Althaus et al. 
(2011) reported on one trial looking at case-management approaches, which 
found that targeting frequent hospital ED users was cost-effective because 
the intervention led to improved clinical and social outcomes at a similar 
cost to usual care. Based on three economic studies, Tappenden et al. (2012) 
concluded that while there was a high likelihood of cost savings associated 
with structured home-based, nurse-led health promotion for older people at 
risk of hospital or care home admission, one study suggested that there was 
little or no evidence of incremental QALY gain over usual care.
The remaining six studies reported quantitative fi ndings, using cost per 
QALY as a measure of cost–utility. Two reviews that analysed studies of care 
approaches for people with depression also reported cost per depression-
free day (Gilbody, Bower & Whitty, 2006; van Steenbergen-Weijenburg et al., 
2010). Cost–effectiveness studies considered by reviews related to a wide 
range of initiatives; a common feature was the adoption of a health services 
perspective. Most evidence was for condition-specifi c approaches, focusing on 
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depression (four reviews) (Neumeyer-Gromen et al., 2004; Gilbody, Bower & 
Whitty, 2006; van Steenbergen-Weijenburg et al., 2010; de Bruin et al., 2011), 
COPD (two reviews) (Steuten et al., 2009; de Bruin et al., 2011), diabetes 
(one review) (de Bruin et al., 2011) and heart failure (one review) (de Bruin 
et al., 2011). With regard to depression, the reported incremental cost per 
QALY varied greatly within reviews but there was some similarity in the range 
across different forms of care approaches: disease management conceptualized 
on the basis of the Chronic Care Model ($2518–66 686 per QALY) (de Bruin 
et al., 2011); enhanced primary care involving collaborative care models 
(£8190–19 483 per QALY; cost per depression-free day, £0.5–19) (Gilbody, 
Bower & Whitty, 2006); collaborative care ($21 478–49 500 per QALY; highest 
cost per depression free day, $24) (van Steenbergen-Weijenburg et al., 2010); 
and comprehensive disease management ($9051–49 500) (Neumeyer-Gromen 
et al., 2004). The upper estimate of cost per QALY for disease management 
conceptualized on the basis of the Chronic Care Model for diabetes was similar 
to depression ($34 238–69 027) but was considerably higher for heart failure 
($17 747–156 655) (de Bruin et al., 2011).
Steuten et al. (2009) undertook an assessment of cost–effectiveness based 
on societal willingness to pay. They concluded that disease management for 
COPD would be cost-effective (assuming a willingness to pay €30 000 per 
QALY) if incremental cost per patient did not exceed €7680 over their lifetime. 
Their study also provided illustrative examples of the short-term potential of 
disease management of COPD, with one example of a randomized controlled 
trial of home care of COPD patients in Australia (Hermiz et al., 2002). The 
trial reported a non-signifi cant increase in hospital admissions of 27% and 
a reduction in ED visits. Using these fi gures, Steuten et al. (2009) estimated 
that home care may be cost-effective if the incremental cost was lower than 
AUS$171.36 per patient per year. This means that to achieve a return on 
investment, savings generated would need to more than offset the additional 
costs of hospitalization. 
Regarding non-condition specifi c interventions, Simoens et al. (2011) reported 
on the cost–effectiveness of medication management as part of seamless care 
for patients in transition between ambulatory and hospital care (€13 000 per 
QALY), although this was based on only one study within the review (Simoens 
et al., 2011).
5.3 Cost and/or expenditure
Seventeen reviews reported cost and/or expenditure data in some form 
(Neumeyer-Gromen et al., 2004; Phillips et al., 2004; Langhorne et al., 2005; 
Chiu & Newcomer, 2007; Smith & Newton, 2007; Brink-Huis, van Achterberg 
& Schoonhoven, 2008; Shepperd et al., 2008; Oeseburg et al., 2009; Steffen 
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et al., 2009; Steuten et al., 2009; Pimouguet et al., 2010; van Steenbergen-
Weijenburg et al., 2010; Althaus et el., 2011; de Bruin et al., 2011; Simoens 
et al., 2011; Smith et al., 2012b; Tappenden et al., 2012). Reviews varied 
widely in the way they reported costs. In particular, as indicated in the methods 
section, original studies included in reviews tended to use terms that are 
conceptually different, such as cost, expenditure, cost saving and cost avoided 
interchangeably, which makes it diffi cult to draw comparisons by target area 
or intervention type.
Keeping these limitations in mind, most studies reported cost in terms of 
health-care cost savings resulting from the care initiative under review, most 
frequently in relation to hospital costs. Avoided costs or cost savings were 
typically derived from reduced hospital and emergency room utilization. There 
was some evidence of cost reduction in a number of reviews. However, fi ndings 
were frequently based on a small number of original studies, or studies that 
used a before–after design without control, or both (Phillips et al., 2004; 
Chiu & Newcomer, 2007; Brink-Huis, van Achterberg & Schoonhoven, 2008; 
Shepperd et al., 2008; Steffen et al., 2009; Althaus et el., 2011; Simoens et al., 
2011). Neumeyer-Gromen et al. (2004) and van Steenbergen-Weijenburg et al. 
(2010), both reporting on care approaches for depression, reported an increase 
in costs associated with the intervention, albeit with some evidence of lower 
cost per successfully treated patient. Oeseburg et al. (2009), in their review 
of studies of case management for frail older people or those with chronic 
illness, distinguished between costs accruing to nursing homes, hospitals 
and community health services but found the evidence to be inconclusive.
When reported quantitatively, costs were commonly reported as cost per patient 
or cost per day or month. One study reported cost savings as a percentage, 
with a median saving of 20% (range 4–30%) associated with early supported 
discharge for stroke (Langhorne et al., 2005). Philips et al. (2004) highlighted 
the impact of health system setting on costs, demonstrating how pooled cost 
differences for comprehensive discharge planning for heart failure patients 
ranged from -$359 compared to usual care in non-US based trials to -$536 in 
US trials. Tappenden et al. (2012), in a review of structured home-based, nurse-
led health promotion, further highlighted the importance of differentiating 
between initial and longer term costs. Thus, they reported how a community-
based nursing programme for patients with Parkinson’s disease had initially 
increased costs in the intervention arms, but over two years costs were lower.
6 Discussion
In this report we have reviewed the recent evidence base on the economic 
impacts of care initiatives that can broadly be considered under the heading 
of ‘integrated care’. We show that the evidence was rather mixed and overall 
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very diffi cult to interpret. This is perhaps not surprising, given the range of 
approaches and target groups considered. 
Before discussing our observations in further detail it is important to consider 
some of the limitations of the review presented here. One main limitation is 
that our study includes reviews only. We did not formally assess the reviews for 
quality although we only considered those that quality assessed the original 
studies in individual reviews. However, basing our evidence review on existing 
systematic reviews and meta-analysis implies that, of necessity, we have 
had to rely on authors’ reporting of the original studies. This limits objective 
assessment in particular where observations from original studies were not 
quantifi ed. We noted above how reviews tended to report qualitatively on 
selected measures such as utilization or cost, noting for example ‘signifi cant 
change’ without documenting actual effect sizes and confi dence intervals; 
this makes it diffi cult to independently evaluate reported fi ndings. A related 
limitation is that even the most recent reviews will not refl ect original work 
published over the past 12 months or so, which might have given additional 
insights into our review. However, this was not possible within the time 
available for this work.
More importantly perhaps, we note how none of the reviews explicitly defi ned 
‘integrated care’ as the topic of review. Reviews considered here studied a 
wide range of very varied interventions and care approaches. These included 
elements of integration but of varied complexity that were then subsumed 
under a broad label such as, for example, case management (Oeseburg et al., 
2009; Pimouguet et al., 2010; Althaus et al., 2011). Individual care approaches 
were not necessarily equivalent or comparable in the nature and degree of 
integration, the type of service model, or the health system context within 
which they were embedded, as highlighted earlier. Therefore, it is diffi cult 
for us to draw conclusions on the potential differential impacts of approaches 
evaluated in individual studies. While this can be seen as a refl ection of the 
‘polymorphous nature’ of the concept of integrated care, it also means that 
all-encompassing conclusions will be diffi cult to draw. This challenge has been 
highlighted by others. For example, in a recent commentary on the review by 
Pimouguet et al. (2010) of dementia case management, Koch et al. (2012) 
noted how different understanding and interpretation of what constitutes case 
management will make drawing conclusions of primary studies problematic. 
These concerns echo those reported by Ouwens et al. (2005) and others. Thus, 
it remains a challenge to interpret the evidence from existing primary studies, 
which tend to be characterized by heterogeneity in terms of the defi nition and 
description of the intervention and components of care.
Furthermore, it is important to highlight that our discussion has centred on 
economic impacts of studies that have evaluated integrated care approaches. 
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However, this evidence needs to be set in the context of health and other 
outcomes of the interventions, which we have not specifi cally discussed here. 
This will be particularly important where evaluations of individual interventions 
show an increase in cost while reducing, say, mortality. In order to interpret 
these fi ndings it is important to consider the context in which they have 
been observed.
Previously we have argued how the interpretation of evaluation fi ndings has 
to be placed in the broader context of programme implementation specifi cally 
and issues around evaluation generally (Nolte et al., 2012). For example, where 
an evaluation fi nds improvements in health outcomes but not in ecomomic 
impacts, this might be because the period of evaluation was not suffi cient to 
demonstrate economic gain. Likewise, an evaluation might fi nd that a given 
care approach improved outcomes for a subgroup of participants only; this 
might indicate that the intervention was suboptimal or not suffi ciently targeted 
at those who would benefi t most. Also, intervention effect will differ by target 
population and, importantly, the setting, in particular where initiatives involve 
a complex interplay of different actors as in integrated care approaches.
Against this background, and with a focus on economic impact, it is particularly 
important to understand the quality of the available evidence in order to ‘make 
sense’ of the substantial variation in fi ndings on utilization and costs. Several 
reviews assessed here highlighted the quality of existing economic evaluations 
as the main impediment to arriving at a robust evidence base that is suitable to 
inform decision making. For example, Tappenden et al. (2012), in their review 
of home-based, nurse-led health promotion in the UK identifi ed only a small 
number of economic studies that varied widely in tems of methodological 
approach and measures of impact chosen. We have noted above how Althaus 
et al. (2011), reviewing initatives targeted at frequent users of the emergency 
department, had to rely on before–after studies without appropriate control, 
thus reducing the ability to attribute observed cost reductions to the actual 
intervention. While lack of a comparator to enable attribution of impact is 
problematic in itself, Chiu et al. (2007) further highlighted the added challenge 
of suitability of study design. For example, in their review of nurse-assisted 
case management to improve hospital discharge, six of eight studies that 
reported non-signifi cant fi ndings with regard to readmission rates were based 
on samples of fewer than 100 people per group or lower than 90% retention 
rates. Likewise, de Bruin et al. (2011), in their systematic review of chronic 
care interventions, reported how studies varied substantially with regard to the 
economic evaluative approach adopted, the type of health-care costs and cost 
categories considered, alongside lack of reporting on reliability of estimates, 
highlighting the need for higher quality studies.
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Reviewing economic evaluations of collaborative care models for depression 
in primary care settings, Gilbody et al. (2007) also noted that none of the 
11 studies eligible for inclusion in their review considered costs beyond the 
actual health-care system, such as unemployment benefi ts or lost earnings 
as a consequence of illness. This may be an important point to consider as 
interventions targeted at depression tended to be associated with higher costs 
(Neumeyer-Gromen et al., 2004; van Steenbergen-Weijenburg et al., 2010), 
which might be offset when considering the wider societal costs associated 
with depression in the working- age population. 
However, beyond the specifi c challenges posed by the nature and quality of 
the existing research evidence as it relates to economic outcomes, there is the 
broader question as to whether the concept of ‘integrated care’ lends itself to 
evaluation in a way that would allow for clear-cut or defi nitive evidence, given 
its polymorphous nature. Indeed, if we interpret integrated care initiatives in 
the context of complex health and social care needs as a means to improve 
outcomes by overcoming fragmentation through linkage or coordination of 
services along the continuum of care, related initiatives will have to be targeted 
to the needs of a given population, which in turn will be highly context 
dependent. Therefore, while it may not be possible to generate clear-cut 
evidence as to the effectiveness of diverse and complex programmes such as 
integrated care, there is potential for transferable lessons to be learned across 
different studies to identify core elements that will support better outcomes.
Also, to support this process, there may be a need to revisit the way in which 
evidence is being generated in the fi eld of integrated care to advance our 
understanding of ‘what works’. At the core remains the clear defi nition of 
what constitutes effectiveness (or ‘success’) and, perhaps more critically, 
the hypothesized mechanism(s) of expected effect(s), which requires good 
theoretical understanding of how the intervention causes change and of the 
links within the causal chain (Craig et al., 2008). Much of the available evidence 
on outcomes rests on explicitly quantitative methods. However, as Cretin, 
Shortell & Keeler (2004) have suggested in the context of chronic care, the 
complexity and variability of related interventions and programmes calls for the 
use of mixed-method research methods. While there is an increasing body of 
work in this fi eld, there is relatively little research on methodological, analytical 
or conceptual aspects of the use of qualitative approaches in the evaluation 
of complex care programmes. Recently, there has been a move towards 
emphasizing ‘realistic evaluation’ (Pawson & Tilley, 1997), which uses pluralistic 
quasi-experimental methods for evaluating complex interventions with high 
contextual infl uence, such as integrated care. Realistic evaluation involves 
understanding what works for whom under what circumstances, and places 
equal emphasis on external validity, generalizability and cumulative learning. 
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There may also be a need to revisit our understanding of what integrated care 
is. Earlier sections of this paper have provided an overview of different ways 
of conceptualizing integrated care. Fundamentally however, it is important to 
come to an understanding as to whether integrated care is an intervention that, 
by implication, ought to be cost-effective and support fi nancial sustainability, or 
whether it is a complex strategy to innovate and implement long-lasting change 
in the way services in the health and social-care sectors are being delivered and 
that involve multiple changes at multiple levels. Evidence presented here and 
elsewhere strongly points to the latter, and initiatives and strategies underway 
will require continuous evaluation over extended periods of time that will 
enable assessment of their impacts on both economic and health outcomes. 
This will mean investment in research alongside support of the development 
and implementation of integrated care initiatives to ensure that evaluation 
will inform service development in particular (Goodwin et al., 2012) if we are 
to generate appropriate conclusions about programme effectiveness and the 
application of fi ndings to inform decision-making. 
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